Table 2 The antimicrobial sensitivity tests of MSSA and MRSA isolates by disk diffusion method
Antibiotic | MSSA (n = 122) | MRSA (n = 24) | ||||
|---|---|---|---|---|---|---|
Susceptible N (%) | Intermediate N (%) | Resistant N (%) | Susceptible N (%) | Intermediate N (%) | Resistant N (%) | |
Erythromycin | 62 (50.8) | 32 (26.2) | 28 (23.0) | 5 (20.8) | 2 (8.4) | 17 (70.8) |
Clindamycin | 100 (82.0) | 14 (11.5) | 8 (6.5) | 6 (25.0) | 4 (16.7) | 14 (58.3) |
Cefoxitin | 122 (83.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 24 (16.4) |
Cefazolin | 119 (97.5) | 2 (1.7) | 1 (0.8) | 11 (45.8) | 0 (0.0) | 13 (54.2) |
Linezolid | 120 (98.4) | 0 (0.0) | 2 (1.6) | 23 (95.8) | 0 (0.0) | 1 (4.2) |
Trimethoprim/sulfamethoxazole | 112 (91.8) | 4 (3.3) | 6 (4.9) | 16 (66.7) | 0 (0.0) | 8 (33.3) |